Lüring C, Oczipka F, Bäthis H, Grifka J, Tingart M
Orthopädische Klinik, Universität Regensburg.
Sportverletz Sportschaden. 2006 Sep;20(3):149-52. doi: 10.1055/s-2006-927000.
Symptomatic deep vein thrombosis is a serious complication after total knee arthroplasty, with a risk of about 4-5% despite prevention with herparin. Aim of the current study was to find out about the actual status of thrombosis prophylaxis in Germany after total knee replacement.
In a countrywide survey 470 German trauma and orthopaedic surgery departments were asked about their prophylactic procedures addressing deep vein thrombosis after total knee replacement.
98% perform prevention of thrombosis with low-molecular-weight heparin, 2% use unfractioned heparin. Low-molecular-weight heparin is applicated in standard doses in 48% and in 44% according to patient's weight. In 82% the prophylaxis is begun the night before surgery. The therapy is carried out for 4.7 weeks in mean. 96% use graduated compressions stocking as additional therapeutic option.
Our survey shows that most of the surgeons perform prevention of deep vein thrombosis according to the official guidelines.
症状性深静脉血栓形成是全膝关节置换术后的一种严重并发症，尽管使用肝素进行预防，其风险仍约为4-5%。本研究的目的是了解德国全膝关节置换术后血栓预防的实际情况。
在一项全国性调查中，向470个德国创伤与骨科手术科室询问了他们针对全膝关节置换术后深静脉血栓形成的预防措施。
98%的科室使用低分子肝素预防血栓形成，2%使用普通肝素。48%的科室按标准剂量使用低分子肝素，44%的科室根据患者体重使用。82%的科室在手术前一晚开始预防。治疗平均进行4.7周。96%的科室使用分级加压弹力袜作为额外的治疗选择。
我们的调查表明，大多数外科医生按照官方指南进行深静脉血栓形成的预防。
